Table 1.
Demographic and clinical characteristics of included subjects.
| Variables | ATB (n = 49) | LTBI (n = 64) | HC (n = 95) |
|---|---|---|---|
| Age, years | 48 (29-60) | 50 (40-61) | 47 (33-57) |
| Sex, male, % | 27 (55.1%) | 41 (64.06%) | 60 (63.16%) |
| TB history | 11 (22.45%) | 0 (0%) | 0 (0%) |
| Underlying condition or illness | |||
| Diabetes mellitus | 7 (14.29%) | 8 (12.5%) | 0 (0%) |
| Solid tumor | 5 (10.2%) | 6 (9.38%) | 0 (0%) |
| Hematological malignancy | 1 (2.04%) | 1 (1.56%) | 0 (0%) |
| End-stage renal disease | 4 (8.16%) | 7 (10.94%) | 0 (0%) |
| Liver cirrhosis | 2 (4.08%) | 3 (4.69%) | 0 (0%) |
| Organ transplantation | 2 (4.08%) | 1 (1.56%) | 0 (0%) |
| Immunosuppressive condition* | 7 (14.29%) | 4 (6.25%) | 0 (0%) |
| Positive mycobacterial culture | 40 (81.63%) | NA | NA |
| Positive GeneXpert MTB/RIF | 36 (73.47%) | NA | NA |
ATB, active tuberculosis; LTBI, latent tuberculosis infection; HC, healthy controls; TB, tuberculosis; NA, not applicable.
*Patients who underwent organ transplantation, chemotherapy or took immunosuppressants within 3 months. Data were presented as medians (25th-75th percentiles) or numbers (percentages).